Michael Voss, who is CEO of Fundamental Fondsmæglerskab, has given Hvidovre hospital a helping hand in the form of economic assistance.
The money will be spent on wages for one of the two researchers at the hospital who have just started a trial to test the effects of malaria medicine klorokin as a preventative and curative treatment for coronavirus.
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for AMWatch has now started
With your free trial you get:
Full access to all locked articles on AMWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.